Shirley V. Hodgson

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

John Burn, Anne‐Marie Gerdes, Finlay Macrae et al. · The Lancet · 2011 · 951 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Multiple Colorectal Adenomas, Classic Adenomatous Polyposis, and Germ-Line Mutations in<i>MYH</i>

Oliver M. Sieber, Lara Lipton, Michael Crabtree et al. · New England Journal of Medicine · 2003 · 860 citations

Life Sciences, Genetics, Molecular Genetics +17

Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts

Hans F. A. Vasen, Ignacio Blanco, Katja Aktan–Collan et al. · Gut · 2013 · 744 citations · Full text

Medicine, Cardiology, Internal Medicine +7

Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors

Toshiyasu Taniguchi, Marc Tischkowitz, Najim Ameziane et al. · Nature Medicine · 2003 · 543 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial

John Burn, Harsh Sheth, Faye Elliott et al. · The Lancet · 2020 · 403 citations · Full text

Medicine, Pharmacotherapy, Preventive Medicine +16